Re: ZEN-3694 Single Agent Trial Status
posted on
Sep 19, 2017 01:04PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Three for three in favor of both being taken out in one deal. I would be totally happy to be wrong. Thanks for playing the game.
tada